Ramboll announces senior Life Sciences and Pharmaceuticals hires

Global engineering and sustainability consultancy appoints Richard Linacre and Ivana Poparic as Directors in its Life Sciences and Pharmaceuticals teams

Ramboll has today announced the hires of Richard Linacre as Director (Pharmaceuticals) and Ivana Poparic as Director (Business Development & Strategic Advisory). Richard and Ivana bring complementary expertise that further strengthens Ramboll’s presence across the UK Life Science and Pharmaceuticals market, following a number of recent wins for the business.

 With over 30 years of engineering experience, Richard brings a wealth of market insight and pharma-sector expertise, underpinned by a proven track record in building trusted client partnerships, leading complex programmes and shaping high-quality outcomes across pharmaceutical and life science environments.

In his role Richard will be focusing on co-ordinating Ramboll’s multi-disciplinary capabilities on projects across Life Sciences and Pharmaceuticals. This will include work both in the UK and internationally across the sector, delivering innovation with a focus on design excellence and sustainability.

As Business Development & Strategic Advisory Director, Ivana will leverage Ramboll’s multidisciplinary expertise to support the delivery of complex projects and provide strategic counsel to clients across the life sciences sector.

Having previously held positions at King’s College London, The National Institute for Health and Care Research (NIHR) and MedCity, Ivana is a highly respected scientist and a well-known expert in life sciences infrastructure development and ecosystems. She will bring considerable strategic advisory experience and a strong track record to Ramboll, having built partnerships across industry, investors, government, academia and real estate to support Ramboll’s growth and innovation.

Together these appointments further enhance Ramboll’s ability to create new opportunities for collaboration and growth, enhance the company’s offering, and reinforce its commitment to supporting its clients across the Life Science and Pharmaceutical sector.

Commenting on the appointments, Jason Layfield, Executive Director – Buildings, said:

“We are delighted to be welcoming Richard and Ivana to Ramboll. Both arrive with a well-earned reputation for excellence in their fields and a proven track record of delivering commercial success. They will provide an important focal point and leadership for our pharmaceutical and life sciences teams in the UK. I am looking forward to working closely alongside them both.”

Richard Linacre, Director – Pharmaceuticals added:

“Ramboll’s track-record in delivering the highest quality of work speaks for itself and I’m excited to be joining a company that shares my commitment to providing across-the-board excellence to clients. I have been impressed by Ramboll’s expertise, collaborative approach and use of creativity to develop novel solutions, which provide real impact for projects of significant scale and the breadth in the sector. It’s a timely moment to be joining with both life sciences and the business experiencing growth and I’m glad to be here to help maximise the opportunity.”

Ivana Poparic, Director Business Development & Strategic Advisory – said:

“I am pleased to be joining Ramboll to help deliver further growth in life sciences and pharma in the UK. Ramboll already has a first-class reputation in this space, which is part of what made me so keen to take on this role. I have seen firsthand both the challenges and opportunities for life sciences development in the UK and Ramboll’s ability to exceed expectations to meet them through its holistic approach. I’m looking forward to delivering positive outcomes for our life sciences clients as their sustainable partner for change.”